BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tanemura M, Miyoshi E, Nagano H, Eguchi H, Matsunami K, Taniyama K, Hatanaka N, Akamatsu H, Mori M, Doki Y. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction. World J Gastroenterol 2015; 21(40): 11396-11410 [PMID: 26523105 DOI: 10.3748/wjg.v21.i40.11396]
URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11396.htm
Number Citing Articles
1
Eiji Miyoshi, Yoshihiro Kamada. Application of glycoscience to the early detection of pancreatic cancerCancer Science 2016; 107(10): 1357 doi: 10.1111/cas.13011
2
Andreas Zappe, Julia Rosenlöcher, Guido Kohla, Stephan Hinderlich, Maria Kristina Parr. Purification and Characterization of Antibodies Directed against the α-Gal EpitopeBioChem 2021; 1(2): 81 doi: 10.3390/biochem1020008
3
Uri Galili. The Natural Anti-Gal Antibody As Foe Turned Friend In Medicine2018; : 171 doi: 10.1016/B978-0-12-813362-0.00010-5
4
Fengzhen Mo, Dabing Xue, Siliang Duan, Aiqun Liu, Xiaomei Yang, Xiaoqiong Hou, Xiaoling Lu. Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancerVaccine 2019; 37(7): 926 doi: 10.1016/j.vaccine.2019.01.004
5
Jian He, Yu Huo, Zhikun Zhang, Yiqun Luo, Xiuli Liu, Qiaoying Chen, Pan Wu, Wei Shi, Tao Wu, Chao Tang, Huixue Wang, Lan Li, Xiyu Liu, Yong Huang, Yongxiang Zhao, Lu Gan, Bing Wang, Liping Zhong. Generation of αGal-enhanced bifunctional tumor vaccineActa Pharmaceutica Sinica B 2022; 12(7): 3177 doi: 10.1016/j.apsb.2022.03.002
6
Shanni Hong, Pi Ding, Yu Luo, Tian Gao, Ye Zhang, Renjun Pei. Aptamer‐integrated α‐Gal liposomes as bispecific agents to trigger immune response for killing tumor cellsJournal of Biomedical Materials Research Part A 2019; 107(6): 1176 doi: 10.1002/jbm.a.36609
7
Didier Dréau, Laura Jeffords Moore, Mike Wu, Lopa Das Roy, Lloye Dillion, Travis Porter, Rahul Puri, Noor Momin, K. Dane Wittrup, Pinku Mukherjee. Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal AdenocarcinomaFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00330
8
Boyuan Guan, Zhenghan Zhang, Xiaoyu Liu, Shanshan Zhao, Xue Bai, Xue Luo, Daguang Feng, Liu Yang, Xueyan Cao, Xiqing Yue. Quantitative label-free site-specific glycoproteomic analysis of the milk fat globule membrane protein in human colostrum and mature milkCarbohydrate Polymers 2023; 306: 120588 doi: 10.1016/j.carbpol.2023.120588